The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.

The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).

The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.

The IJC Strategic Plan 2026–2030 aims to build an integrated research ecosystem connecting the Institute, its affiliated hospitals, partner research centres and the Catalan public health system.

At the centre of the Strategy are major cross-cutting initiatives designed to strengthen collaboration between laboratory and clinical research, develop shared capabilities for patient samples and data, and advance new approaches to diagnostics, precision medicine and therapeutic development.

We are seeking a Mission Project Manager to support the effective implementation of this Strategy across the Institute and its partner organisations.

Reporting to the Mission Lead, the Mission Project Manager will maintain an institute-wide view of implementation, identify barriers to progress, facilitate resolution of cross-cutting issues and ensure that agreed decisions and actions are followed through to completion. This is a transversal coordination role requiring regular interaction with scientific and administrative leaders, clinicians, researchers and external institutional partners.

MAIN RESPONSABILITIES

• Assist in monitoring the progress of the Strategic Plan across its different programmes, workstreams and partner institutions. Maintain an up-to-date overview of milestones, key activities, decisions, risks and outstanding actions. Identify dependencies and necessary changes.

• Contribute to strengthening the governance and implementation processes that support the Strategic Plan and escalate significant issues to the Mission Lead or Institute leadership when needed.

• Bring together the right scientific, clinical and administrative stakeholders to resolve cross-cutting issues and prepare focused meetings that lead to final decisions.

• Maintain central records: Keep a clear, structured, and up-to-date repository of key activities, decisions, risks, and outstanding actions across the Strategy.

• Meeting organization and logistics: Coordinate logistics for strategic review meetings, workshops, and committees, ensuring room bookings, calendar invites, and technical setups are managed efficiently.

• Documentation and minutes: Prepare templates, compile necessary documentation prior to meetings, and draft precise minutes, action items, and deadlines.

• Report preparation: Assist in compiling and formatting concise materials, presentations, and progress reports for monthly, quarterly, and other strategic review meetings.

WHAT WE NEED

Essential requirements

• PhD (or equivalent) in Life Sciences or related field, or equivalent research experience, with scientific knowledge to engage across basic, translational, clinical and computational research.

• Background in a research institute, hospital or public research/health administration, with proven experience coordinating complex, multi-stakeholder activities.

• Strong planning and oversight of parallel priorities, combined with the ability to diagnose root causes of delays and drive solutions.

• Diplomatic, effective communication with senior stakeholders, and persistence in following up on commitments.

• Working knowledge of Catalan, Spanish and English, plus standard digital tools for collaboration, tracking and reporting.

Additional experience valued

• Experience within the Catalan research/public health ecosystem, ideally coordinating multi-institution programmes or strategic initiatives.

• Familiarity with project-management, workflow or business-intelligence tools.

Skills and competences

• Ability to understand the broader strategic picture while maintaining attention to operational detail.

• Clear, concise communicator who builds trust and relationships across boundaries without relying on formal authority.

• Reliable, discreet and able to work independently while staying collaborative.

WHAT WE OFFER

• Contract “Indefinido por actividades científico técnicas” linked to the implementation of the Strategic plan until 2030. The continuity of the position is linked to budgetary availability and favorable follow-up of the initiatives achieved.

• Full-time position (39h per week).

• Measures to reconcile work and family life (flexible work schedule, teleworking, 23 working days of vacation and 12 days for personal matters in 2026).

• Flexible remuneration program

• Training opportunities.

• Spanish/Catalan/English language courses, if required.

• Join a highly collaborative team and engage in exciting projects.

• Work within a dynamic environment blending basic and clinical research.

• Enjoy the vibrant surroundings of the Barcelona metropolitan area, IJC headquarters located in nature.

DEADLINE

Please submit your application by 16/10/2026.

WHO WE ARE?

What makes us different?

The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.

HR Excellence

In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start-up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.

The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.